Evidence map›Paper›PMID 31075137›Full record

ArticlePloS one2019

Genotypic antimicrobial resistance assays for use on E. coli isolates and stool specimens.

Suporn Pholwat, Jie Liu, Mami Taniuchi, Rattapha Chinli, Tawat Pongpan, Iyarit Thaipisutikul, Parntep Ratanakorn, James A Platts-Mills, Molly Fleece, Suzanne Stroup and 8 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tracking the Prevalence of Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. Open forum infectious diseases · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Use of Molecular Methods To DetectJournal of clinical microbiology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Antibiotic Resistance in Recreational Waters: State of the Science.International journal of environmental research and public health · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Suporn PholwatDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Jie LiuDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Mami TaniuchiDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Rattapha ChinliDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Tawat PongpanSwine Veterinarian Service, Charoen Pokphand Foods PCL, Bangkok, Thailand.
Iyarit ThaipisutikulDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Parntep RatanakornFaculty of Veterinary Science, Mahidol University, Nakhonpathom, Thailand.
James A Platts-MillsDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Molly FleeceDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Suzanne StroupDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Jean GratzDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.
Esto MdumaHaydom Lutheran Hospital, Haydom, Tanzania.
Buliga MujagaKilimanjaro Clinical Research Institute, Moshi, Tanzania.
Thomas WalongoHaydom Lutheran Hospital, Haydom, Tanzania.
Rosemary NshamaHaydom Lutheran Hospital, Haydom, Tanzania.
Caroline KimathiHaydom Lutheran Hospital, Haydom, Tanzania.
Suporn FoongladdaDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Eric R HouptDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0000-0003-1085-1354

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious DiseasesK24AI102972 · NIAID · UNIVERSITY OF VIRGINIA · PI HOUPT, ERIC R · 2013 to 2022
$1.5M
NIAID NIH HHS K24 AI102972NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is an emerging public health problem and methods for surveillance are needed. We designed 85 sequence-specific PCR reactions to detect 79 genes or mutations associated with resistance across 10 major antimicrobial classes, with a focus on E. coli. The 85 qPCR assays demonstrated >99.9% concordance with sequencing. We evaluated the correlation between genotypic resistance markers and phenotypic susceptibility results on 239 E. coli isolates. Both sensitivity and specificity exceeded 90% for ampicillin, ceftriaxone, cefepime, imipenem, ciprofloxacin, azithromycin, gentamicin, amikacin, trimethoprim/sulfamethoxazole, tetracycline, and chloramphenicol phenotypic susceptibility results. We then evaluated the assays on direct stool specimens and observed a sensitivity of 97% ± 5 but, as expected, a lower specificity of 75% ± 31 versus the genotype of the E. coli cultured from stool. Finally, the assays were incorporated into a convenient TaqMan Array Card (TAC) format. These assays may be useful for tracking AMR in E. coli isolates or directly in stool for targeted testing of the fecal antibiotic resistome.

Indexed as

GenotypeAnti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliFecesHumansPhenotypePolymerase Chain ReactionSequence Analysis, DNAAnti-Bacterial Agents

Identifiers

PMID31075137
PMCPMC6510447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.